SHL Group has announced it will be participating in the BIO International Convention in Boston, Massachusetts, US.
From 4 June to 7 June, SHL will be at Booth #2525 to show its range of patient-friendly drug delivery solutions, which can accommodate any formulation for subcutaneous and intramuscular injection, including low-viscosity, high-viscosity, high-volume and unstable solutions.
Representatives will also be on-site to introduce SHL’s turnkey solution, which leverages a full suite of in-house capabilities to take clients from device design to finished product distribution.
Drawing more than 16,000 participants from 5,000 companies last year, BIO International Convention is a premier biotech convention for industry partnering, education, and networking. SHL looks forward to connecting with top biotech and pharmaceutical companies and helping them meet their clinical and commercial needs.
To learn more about SHL’s offering, visit at Booth #2525 at the Boston Convention & Exhibition Center.